Interventional & Structural Cardiologist @KPcolorado | @CookCtyHealth @RushGradCollege Alumni | Tweets are my own ≠ medical advice.
Denver, CO
Joined May 2010
- Tweets616
- Following1K
- Followers1.2K
- Likes4K
Fady Iskander MD, MSc retweeted
From coronary physiology and PCI timing to coronary re-access and coronary obstruction prevention, this State-of-the-Art review provides practical guidance for managing coronary interventions in patients undergoing TAVI. 🔗eurointervention.pcronline.c… #TAVI #CoronaryInterventions #StructuralHeartDisease
@GilbertTangMD
@didier_tchetche
@barbanti_marco
@AnderRegueiro
@nicolo_piazza
@G_Tarantini01
Fady Iskander MD, MSc retweeted
Authors report the first successful use of the UNICORN technique for #TAVR in a native BAV with high risk for coronary obstruction. Careful CT planning was key to procedural success.
Get the details in #JACCINT: jacc.org/doi/10.1016/j.jcin.…
Fady Iskander MD, MSc retweeted
BATMAN was associated with high technical success and effectiveness in preventing #LVOT obstruction and appeared to be safe in ViR and ViV procedures. Adverse events were higher in ViMAC. jacc.org/doi/10.1016/j.jcin.… #JACCINT #TMVR
Fady Iskander MD, MSc retweeted
This bench study defines optimal balloon sizing for UNICORN across common #THV platforms and confirms coronary clearance. It was determined that one index valve resisted intraleaflet deployment. Further clinical validation is required jacc.org/doi/10.1016/j.jcin.… #JACCINT #TAVR
Fady Iskander MD, MSc retweeted
UNICORN during #TAVR was successful in preventing coronary obstruction. Intraprocedural hypotension requiring vasopressor support was frequent. UNICORN should be considered in cases in which lower risk options are unlikely to be successful. jacc.org/doi/10.1016/j.jcin.… #JACCINT
Fady Iskander MD, MSc retweeted
TAVI in TAVI at high risk of occlusion managed with UNICORN of the LCC and LLAMCORN on the RCC. Successful implant of a Sapien 26 mm with touble tap, no leak, patent coronaries, mean gradient 6 mmHg
Fady Iskander MD, MSc retweeted
This State-of-the-Art review provides a comprehensive and practical overview of coronary interventions related to TAVI, encompassing coronary evaluation and physiological assessment, the indications and timing of percutaneous coronary intervention before and after valve implantation, and strategies for managing coronary obstruction. eurointervention.pcronline.c…
Fady Iskander MD, MSc retweeted
1/8
🚨 The results of CLOSURE-AF are in, providing a sobering look at Left Atrial Appendage Closure (LAAC).
This was the first trial to test the device against modern DOAC therapy in the high-risk patients seen in daily practice.
The verdict: LAAC failed to meet non-inferiority
Fady Iskander MD, MSc retweeted
JUST OUT #JACCINT @JACCJournals . SOTA comprehensive review on #PVL diagnosis and management post #TAVR.
jacc.org/doi/full/10.1016/j.…
Fady Iskander MD, MSc retweeted
JUST OUT! Our official "Double-tap" Sapien 3 Ultra Resilia #TAVR paper is here #JACCINT @JACCJournals, showing double-tap post-dilatation optimizes S3UR expansion on fluoro. This has now become standard practice @MountSinaiHeart and many centers worldwide! Nice editorial by @ronwaksman and Viewpoints by the #Vancouver group!
jacc.org/doi/10.1016/j.jcin.…
jacc.org/doi/10.1016/j.jcin.…
jacc.org/doi/10.1016/j.jcin.…
@MountSinaiNYC
@IcahnMountSinai
@ParasuramMD
@DoctorKini
@KHERA_MD
@LucySafi
@sunnygoelmd
@AmithoodaMD
@georgedangas
@DrDavidReich
@Dr_BrendanCarr
@DLBHATTMD
Fady Iskander MD, MSc retweeted
6 yrs after surgery or #TAVR with CoreValve/Evolut, low-risk AS pts showed no difference in all-cause mortality or disabling #stroke in the Evolut Low-Risk trial. However, reinterventions were higher after TAVR, largely driven by increased AR. jacc.org/doi/10.1016/j.jacc.… #JACC
Fady Iskander MD, MSc retweeted
JUST OUT #JACCINT @JACCJournals ! Our Redo #TAVR concept and planning simplified. Coronary Risk Zone (CRZ) denotes the zone that you MUST measure the valve to coronary/aorta/STJ distance to assess coronary obstruction risk. The minimal distance is what matter most. Great work by @OleDeBacker @bapat_savrtavr @Miho_Fukui_ @SyedZaid to help move this field forward!
jacc.org/doi/10.1016/j.jcin.…
Fady Iskander MD, MSc retweeted
Bicuspid is no longer a niche.
In this SOTA, @didier_tchetche et al walk through TAVI in BAV: phenotypes, CT sizing (BAVARD, circle, CASPER), procedural tricks, long-term concerns and the need for TAVI vs SAVR RCTs.
Don't miss it 👉eurointervention.pcronline.c…
#TAVI #cardiotwitter #CardioX #CardioEd
@YWillemen
@Vinscesario
Fady Iskander MD, MSc retweeted
IV #thrombolysis 4.5–24h post-stroke improves outcomes but increases sICH risk.
Tenecteplase ≈ Alteplase, with less bleeding trend.
#Stroke @amirghabousian @AlimoradiMD @fady_iskander @azeemlatib @ToshikiKuno @RamchandPreethi
ahajournals.org/doi/10.1161/…
Fady Iskander MD, MSc retweeted
Transapical UNICORN to facilitate valve in valve TAVR.
@MCWcardiology
onlinelibrary.wiley.com/shar…
Fady Iskander MD, MSc retweeted
Transcatheter Valve Replacement in Adults with Congenital Heart Disease. Is there limited prothesis longevity in this patient population? @EleidMack @Dr_JHAnderson ahajrnls.org/4nB5mzo
